Should Prenatal Chromosomal Microarray Analysis Be Offered for Isolated Fetal Growth Restriction? A French Multicenter Study. Issue 6 (June 2022)

• Record Type: Journal Article
• Authors: Monier, Isabelle; Receveur, Aline; Houfflin-Debarge, Véronique; Goua, Valérie; Castaigne, Vanina; Jouannic, Jean-Marie; Mousty, Eve; Saliou, Anne-Hélène; Bouchghoul, Hanane; Rousseau, Thierry; Valat, Anne-Sylvie; Groussolles, Marion; Fuchs, Florent; Benoist, Guillaume; Degre, Sophie; Massardier, Jérôme; Tsatsaris, Vassilis; Kleinfinger, Pascale; Zeitlin, Jennifer; Benachi, Alexandra
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 6(2022)
• Page Start: 336
• Page End: 338
• Publication Date: 2022-06
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000831036.52081.a6
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Am J Obstet Gynecol 2021;225:676.e1–676.e15) One common cause of perinatal mortality is fetal growth restriction (FGR), which is associated with neurodevelopmental impairment, other neonatal morbidities, as well as a risk of adult vascular disease. Estimated fetal weight of <10th percentile for gestational age is generally used as diagnostic criteria for FGR diagnosis.